Multiple Sclerosis In 2017: Progress In Multiple Sclerosis — From Diagnosis To Therapy
NATURE REVIEWS NEUROLOGY
Maria Trojano & Maria Pia Amato
Nature Reviews Neurology 14, 72–74 (2018)
In 2017, extensive research into multiple sclerosis (MS) resulted in improved diagnostic criteria, development of biomarkers that enable monitoring of disease evolution and treatment response over time, and identification of novel genetic markers of disease susceptibility. In addition, 2017 saw the first successful clinical trials of remyelination strategies and treatments for progressive MS.
Share this page